Cargando…

Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL

Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Donté Alexander, Beierschmitt, Christopher, Mahesula, Swetha, Corley, Miles R, Salogiannis, John, Tsu, Brian V, Cao, Bryant, Ryan, Andrew P, Hakozawki, Hiroyuki, Reck-Peterson, Samara L, Daugherty, Matthew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651953/
https://www.ncbi.nlm.nih.gov/pubmed/36222652
http://dx.doi.org/10.7554/eLife.81606
_version_ 1784828360952643584
author Stevens, Donté Alexander
Beierschmitt, Christopher
Mahesula, Swetha
Corley, Miles R
Salogiannis, John
Tsu, Brian V
Cao, Bryant
Ryan, Andrew P
Hakozawki, Hiroyuki
Reck-Peterson, Samara L
Daugherty, Matthew D
author_facet Stevens, Donté Alexander
Beierschmitt, Christopher
Mahesula, Swetha
Corley, Miles R
Salogiannis, John
Tsu, Brian V
Cao, Bryant
Ryan, Andrew P
Hakozawki, Hiroyuki
Reck-Peterson, Samara L
Daugherty, Matthew D
author_sort Stevens, Donté Alexander
collection PubMed
description Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor, ninein-like (NINL), as a critical component in the antiviral innate immune response and as a target of viral antagonism. Unique among genes encoding components of active dynein complexes, NINL has evolved under recurrent positive (diversifying) selection, particularly in its carboxy-terminal cargo-binding region. Consistent with a role for NINL in host immunity, we demonstrate that NINL knockout cells exhibit an impaired response to interferon, resulting in increased permissiveness to viral replication. Moreover, we show that proteases encoded by diverse picornaviruses and coronaviruses cleave and disrupt NINL function in a host- and virus-specific manner. Our work reveals the importance of NINL in the antiviral response and the utility of using signatures of host–virus genetic conflicts to uncover new components of antiviral immunity and targets of viral antagonism.
format Online
Article
Text
id pubmed-9651953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-96519532022-11-15 Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL Stevens, Donté Alexander Beierschmitt, Christopher Mahesula, Swetha Corley, Miles R Salogiannis, John Tsu, Brian V Cao, Bryant Ryan, Andrew P Hakozawki, Hiroyuki Reck-Peterson, Samara L Daugherty, Matthew D eLife Immunology and Inflammation Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor, ninein-like (NINL), as a critical component in the antiviral innate immune response and as a target of viral antagonism. Unique among genes encoding components of active dynein complexes, NINL has evolved under recurrent positive (diversifying) selection, particularly in its carboxy-terminal cargo-binding region. Consistent with a role for NINL in host immunity, we demonstrate that NINL knockout cells exhibit an impaired response to interferon, resulting in increased permissiveness to viral replication. Moreover, we show that proteases encoded by diverse picornaviruses and coronaviruses cleave and disrupt NINL function in a host- and virus-specific manner. Our work reveals the importance of NINL in the antiviral response and the utility of using signatures of host–virus genetic conflicts to uncover new components of antiviral immunity and targets of viral antagonism. eLife Sciences Publications, Ltd 2022-10-12 /pmc/articles/PMC9651953/ /pubmed/36222652 http://dx.doi.org/10.7554/eLife.81606 Text en © 2022, Stevens, Beierschmitt et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Immunology and Inflammation
Stevens, Donté Alexander
Beierschmitt, Christopher
Mahesula, Swetha
Corley, Miles R
Salogiannis, John
Tsu, Brian V
Cao, Bryant
Ryan, Andrew P
Hakozawki, Hiroyuki
Reck-Peterson, Samara L
Daugherty, Matthew D
Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title_full Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title_fullStr Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title_full_unstemmed Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title_short Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
title_sort antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor ninl
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651953/
https://www.ncbi.nlm.nih.gov/pubmed/36222652
http://dx.doi.org/10.7554/eLife.81606
work_keys_str_mv AT stevensdontealexander antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT beierschmittchristopher antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT mahesulaswetha antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT corleymilesr antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT salogiannisjohn antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT tsubrianv antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT caobryant antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT ryanandrewp antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT hakozawkihiroyuki antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT reckpetersonsamaral antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl
AT daughertymatthewd antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl